PortfoliosLab logoPortfoliosLab logo
IBRN vs. IBIT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBRN vs. IBIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Neuroscience and Healthcare ETF (IBRN) and iShares Bitcoin Trust ETF (IBIT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBRN achieves a 4.62% return, which is significantly higher than IBIT's -23.36% return.


IBRN

1D
-4.52%
1M
-1.90%
YTD
4.62%
6M
12.73%
1Y
52.57%
3Y*
11.10%
5Y*
10Y*

IBIT

1D
-6.03%
1M
-14.44%
YTD
-23.36%
6M
-26.36%
1Y
-35.90%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBRN vs. IBIT - Yearly Performance Comparison


2026 (YTD)20252024
IBRN
iShares Neuroscience and Healthcare ETF
4.62%28.49%-1.58%
IBIT
iShares Bitcoin Trust ETF
-23.36%-6.41%99.21%

Correlation

The correlation between IBRN and IBIT is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.37

Correlation (All Time)
Calculated using the full available price history since Jan 12, 2024

0.34

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBRN vs. IBIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRN
IBRN Risk / Return Rank: 6969
Overall Rank
IBRN Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
IBRN Sortino Ratio Rank: 6262
Sortino Ratio Rank
IBRN Omega Ratio Rank: 5353
Omega Ratio Rank
IBRN Calmar Ratio Rank: 9292
Calmar Ratio Rank
IBRN Martin Ratio Rank: 7979
Martin Ratio Rank

IBIT
IBIT Risk / Return Rank: 22
Overall Rank
IBIT Sharpe Ratio Rank: 22
Sharpe Ratio Rank
IBIT Sortino Ratio Rank: 22
Sortino Ratio Rank
IBIT Omega Ratio Rank: 22
Omega Ratio Rank
IBIT Calmar Ratio Rank: 22
Calmar Ratio Rank
IBIT Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRN vs. IBIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and iShares Bitcoin Trust ETF (IBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBRNIBITDifference

Sharpe ratio

Return per unit of total volatility

2.09

-0.83

+2.91

Sortino ratio

Return per unit of downside risk

2.94

-1.09

+4.03

Omega ratio

Gain probability vs. loss probability

1.34

0.88

+0.46

Calmar ratio

Return relative to maximum drawdown

6.30

-0.73

+7.03

Martin ratio

Return relative to average drawdown

15.59

-1.27

+16.87

IBRN vs. IBIT - Sharpe Ratio Comparison

The current IBRN Sharpe Ratio is 2.09, which is higher than the IBIT Sharpe Ratio of -0.83. The chart below compares the historical Sharpe Ratios of IBRN and IBIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBRNIBITDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.09

-0.83

+2.91

Sharpe Ratio (All Time)

Calculated using the full available price history

0.37

0.32

+0.04

Drawdowns

IBRN vs. IBIT - Drawdown Comparison

The maximum IBRN drawdown since its inception was -35.38%, smaller than the maximum IBIT drawdown of -49.36%. Use the drawdown chart below to compare losses from any high point for IBRN and IBIT.


Loading charts...

Drawdown Indicators


IBRNIBITDifference

Max Drawdown

Largest peak-to-trough decline

-35.38%

-49.36%

+13.98%

Max Drawdown (1Y)

Largest decline over 1 year

-8.80%

-49.36%

+40.56%

Max Drawdown (3Y)

Largest decline over 3 years

-35.38%

Current Drawdown

Current decline from peak

-6.28%

-46.63%

+40.35%

Average Drawdown

Average peak-to-trough decline

-9.83%

-15.96%

+6.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.56%

28.28%

-24.72%

Volatility

IBRN vs. IBIT - Volatility Comparison

The current volatility for iShares Neuroscience and Healthcare ETF (IBRN) is 7.66%, while iShares Bitcoin Trust ETF (IBIT) has a volatility of 9.76%. This indicates that IBRN experiences smaller price fluctuations and is considered to be less risky than IBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBRNIBITDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.66%

9.76%

-2.10%

Volatility (6M)

Calculated over the trailing 6-month period

19.29%

34.85%

-15.56%

Volatility (1Y)

Calculated over the trailing 1-year period

25.38%

43.65%

-18.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.32%

50.20%

-24.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.32%

50.20%

-24.88%

IBRN vs. IBIT - Expense Ratio Comparison

IBRN has a 0.47% expense ratio, which is higher than IBIT's 0.25% expense ratio.


Dividends

IBRN vs. IBIT - Dividend Comparison

IBRN's dividend yield for the trailing twelve months is around 0.95%, while IBIT has not paid dividends to shareholders.


PositionTTM202520242023
IBIT
iShares Bitcoin Trust ETF
0.00%0.00%0.00%0.00%
IBRN
iShares Neuroscience and Healthcare ETF
0.95%0.99%0.40%0.06%

Frequently Asked Questions


IBRN and IBIT have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBIT has higher volatility (9.76%) compared to IBRN (7.66%). In terms of maximum drawdown, IBRN dropped -35.38% vs IBIT's -49.36%.

On 1-year performance, IBRN leads with 52.57% vs -35.90% for IBIT. On fees, IBIT is cheaper at 0.25% per year. On volatility, IBRN has been the lower-risk option at 7.66%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, IBRN has performed better with a 52.57% return vs -35.90%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IBIT is cheaper with a 0.25% expense ratio, compared with 0.47% for IBRN.

IBRN has the higher dividend yield at 0.95%, compared with 0.00% for IBIT.

IBRN is categorized as Health & Biotech Equities, while IBIT is Cryptocurrency. IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index, while IBIT tracks CME CF Bitcoin Reference Rate - New York Variant. Their fees differ too: 0.47% for IBRN and 0.25% for IBIT.

IBRN currently has the higher Sharpe Ratio (2.09 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBRN and IBIT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer